LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

Drug Safety Update — United Kingdom

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 14 Oct 2026 08:50.

All Recalls and defects4 Serious shortages (SSP) New approvals3 Drug Safety Update

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

10 Jun 2025Tuesday 10 June 2025

open day ◀ ▶ 1 event · 1 important
Updated safety and educational materials are now available to support the implementation of the regulatory measures announced in the November 2023 National Patient Safety Alert and the September 2024 …
What this means, batches, details

Loading…

15 May 2025Thursday 15 May 2025

open day ◀ ▶ 1 event · 1 important
Intrahepatic cholestasis of pregnancy (ICP) has been rarely reported in patients treated with azathioprine products and is believed to be a risk applicable to all drugs in the thiopurine class (azathi…
What this means, batches, details

Loading…

7 May 2025Wednesday 7 May 2025

open day ◀ ▶ 1 event · 1 important
Psychological side effects such as anxiety, low mood, sleep disturbance, poor concentration, and forgetfulness have been infrequently reported in people with cystic fibrosis treated with Kaftrio. Heal…
What this means, batches, details

Loading…

24 Apr 2025Thursday 24 April 2025

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Short
Healthcare professionals and patients are reminded of the risk of severe asthma attacks and increased mortality associated with overuse of SABA with or without anti-inflammatory maintenance therapy in…
What this means, batches, details

Loading…

10 Apr 2025Thursday 10 April 2025

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Fezolinetant▼(Veoza)
Fezolinetant treatment is associated with a risk of drug induced liver injury. New recommendations have been introduced to minimise this risk. Liver function should be monitored before and during trea…
What this means, batches, details

Loading…

In total 59 events in this category.